Principia Biopharma Receives $12,500,000 Series B Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d08527b4-30b4-40e5-8656-9e6ccee1c300&Preview=1 -
Date
10/29/2012 -
Company Name
Principia Biopharma -
Mailing Address
Undisclosed Menlo Park, CA 94025 -
Company Description
The compnay develops unspecified biotheraputic products. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$12,500,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds from this most recent financing will be used to advance Principia’s lead molecule towards the clinic and to develop additional programs enabled by the company’s reversible covalent platform. -
M&A Terms
-
Venture Investor
New Leaf Venture Partners -
Venture Investor
OrbiMed Advisors -
Venture Investor
Morgenthaler Ventures -
Venture Investor
SR One -
Venture Investor
Mission Bay Capital
